GSA Capital Partners’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,308	Closed	-$474K	–	1709
2025 Q3	$474K	Buy	+18,308	New	+$424K	0.04%	877
2025 Q2	–	Sell	-62,326	Closed	-$1.13M	–	1784
2025 Q1	$1.13M	Buy	+62,326	New	+$1.39M	0.1%	288
2024 Q4	–	Sell	-16,114	Closed	-$548K	–	1652
2024 Q3	$548K	Buy	16,114 +10,581	+191%	+$403K	0.04%	848
2024 Q2	$205K	Sell	5,533 -1,508	-21%	-$56.9K	0.01%	1447
2024 Q1	$296K	Buy	+7,041	New	+$289K	0.02%	1224
2023 Q4	–	Sell	-44,716	Closed	-$1.23M	–	1541
2023 Q3	$1.23M	Buy	44,716 +29,404	+192%	+$922K	0.11%	298
2023 Q2	$520K	Sell	15,312 -9,630	-39%	-$325K	0.05%	708
2023 Q1	$897K	Buy	+24,942	New	+$1.08M	0.09%	373
2022 Q4	–	Sell	-11,116	Closed	-$312K	–	1516
2022 Q3	$312K	Buy	+11,116	New	+$341K	0.04%	899
2022 Q1	–	Sell	-18,726	Closed	-$724K	–	1467
2021 Q4	$724K	Buy	+18,726	New	+$816K	0.09%	368
2021 Q3	–	Sell	-9,769	Closed	-$327K	–	1473
2021 Q2	$327K	Buy	+9,769	New	+$268K	0.04%	898
2019 Q1	–	Sell	-52,617	Closed	-$156K	–	1463
2018 Q4	$156K	Sell	52,617 -32,083	-38%	-$158K	0.02%	1155
2018 Q3	$573K	Buy	84,700 +42,047	+99%	+$294K	0.03%	1000
2018 Q2	$322K	Buy	+42,653	New	+$570K	0.02%	1359
2015 Q3	–	Sell	-6,938	Closed	-$2.63M	–	1772
2015 Q2	$2.63M	Buy	6,938 +3,254	+88%	+$1.29M	0.1%	218
2015 Q1	$1.54M	Buy	+3,684	New	+$1.32M	0.06%	522
2014 Q2	–	Sell	-803	Closed	-$213K	–	1818
2014 Q1	$213K	Sell	803 -1,464	-65%	-$561K	0.02%	1344
2013 Q4	$823K	Sell	2,267 -1,366	-38%	-$526K	0.07%	485
2013 Q3	$1.93M	Buy	3,633 +12	+0.3%	+$4.12K	0.15%	130
2013 Q2	$848K	Buy	+3,621	New	+$713K	0.1%	272